Literature DB >> 20333788

Effect of Recql5 deficiency on the intestinal tumor susceptibility of Apc(min) mice.

Yiduo Hu1, Xincheng Lu, Guangbin Luo.   

Abstract

AIM: To investigate whether Recql5, a DNA helicase that plays an important role in the maintenance of genome integrity, is a tumor suppressor in the gastrointestinal tract in mice.
METHODS: We generated cohorts of both Recql5-proficient and Recql5-deficient Apc(min/+) mice and compared the tumor susceptibility in their gastrointestinal tracts.
RESULTS: Recql5 deficiency in Apc(min/+) mice resulted in a significant increase in the tumor incidence in both the colon (P = 0.0162) and the small intestine (P < 0.01). These findings have provided the first genetic evidence for a tumor suppression role of Recql5 in the gastrointestinal tract of mice. Importantly, since mouse Recql5 and human RECQL5 are highly conserved, these findings also suggest that RECQL5 may be a tumor suppressor for human colon cancer.
CONCLUSION: Recql5 has a tumor suppression role in the mouse gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20333788      PMCID: PMC2846253          DOI: 10.3748/wjg.v16.i12.1482

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  19 in total

Review 1.  Chromosomal stability and the DNA double-stranded break connection.

Authors:  D C van Gent; J H Hoeijmakers; R Kanaar
Journal:  Nat Rev Genet       Date:  2001-03       Impact factor: 53.242

Review 2.  Lessons from hereditary colorectal cancer.

Authors:  K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

3.  Cancer-susceptibility genes. Gatekeepers and caretakers.

Authors:  K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1997-04-24       Impact factor: 49.962

Review 4.  The retinoblastoma tumour suppressor in development and cancer.

Authors:  Marie Classon; Ed Harlow
Journal:  Nat Rev Cancer       Date:  2002-12       Impact factor: 60.716

Review 5.  Tumor progression: a brief historical perspective.

Authors:  Peter C Nowell
Journal:  Semin Cancer Biol       Date:  2002-08       Impact factor: 15.707

Review 6.  The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions.

Authors:  W F Dove; R T Cormier; K A Gould; R B Halberg; A J Merritt; M A Newton; A R Shoemaker
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

Review 7.  The adenomatous polyposis coli protein: the Achilles heel of the gut epithelium.

Authors:  Inke S Näthke
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

Review 8.  Cancer genes and the pathways they control.

Authors:  Bert Vogelstein; Kenneth W Kinzler
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

Review 9.  The multistep nature of cancer.

Authors:  B Vogelstein; K W Kinzler
Journal:  Trends Genet       Date:  1993-04       Impact factor: 11.639

10.  Direct inhibition of RNA polymerase II transcription by RECQL5.

Authors:  Ozan Aygün; Xiaohua Xu; Yilun Liu; Hidehisa Takahashi; Stephanie E Kong; Ronald C Conaway; Joan W Conaway; Jesper Q Svejstrup
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

View more
  9 in total

1.  RECQL5 has unique strand annealing properties relative to the other human RecQ helicase proteins.

Authors:  Prabhat Khadka; Deborah L Croteau; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2015-12-02

Review 2.  Human RECQL5: guarding the crossroads of DNA replication and transcription and providing backup capability.

Authors:  Venkateswarlu Popuri; Takashi Tadokoro; Deborah L Croteau; Vilhelm A Bohr
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-04-29       Impact factor: 8.250

3.  Tumor suppressor RecQL5 controls recombination induced by DNA crosslinking agents.

Authors:  Yoshifumi Hosono; Takuya Abe; Masamichi Ishiai; M Nurul Islam; Hiroshi Arakawa; Weidong Wang; Shunichi Takeda; Yutaka Ishii; Minoru Takata; Masayuki Seki; Takemi Enomoto
Journal:  Biochim Biophys Acta       Date:  2014-01-10

4.  Recql5 protects against lipopolysaccharide/D-galactosamine-induced liver injury in mice.

Authors:  Wan-Qin Liao; Ya-Lei Qi; Lin Wang; Xiao-Ming Dong; Tao Xu; Chao-Dong Ding; Rui Liu; Wei-Cheng Liang; Li-Ting Lu; He Li; Wen-Feng Li; Guang-Bin Luo; Xin-Cheng Lu
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

5.  Altered RECQ Helicase Expression in Sporadic Primary Colorectal Cancers.

Authors:  Victoria Valinluck Lao; Piri Welcsh; Yanxin Luo; Kelly T Carter; Slavomir Dzieciatkowski; Suzanne Dintzis; Jane Meza; Nora E Sarvetnick; Raymond J Monnat; Lawrence A Loeb; William M Grady
Journal:  Transl Oncol       Date:  2013-08-01       Impact factor: 4.243

Review 6.  Manipulation of DNA Repair Proficiency in Mouse Models of Colorectal Cancer.

Authors:  Michael A Mcilhatton; Gregory P Boivin; Joanna Groden
Journal:  Biomed Res Int       Date:  2016-06-20       Impact factor: 3.411

7.  Comparison of the fertility of tumor suppressor gene-deficient C57BL/6 mouse strains reveals stable reproductive aging and novel pleiotropic gene.

Authors:  Masaoki Kohzaki; Akira Ootsuyama; Toshiyuki Umata; Ryuji Okazaki
Journal:  Sci Rep       Date:  2021-06-11       Impact factor: 4.379

8.  A RecQ Protein-like 5 Haplotype is Associated With Colon Cancer.

Authors:  Heather M Ochs-Balcom; Cheryl L Thompson; Sarah Plummer; Guangbin Luo; Thomas C Tucker; Graham Casey; Li Li
Journal:  Gastroenterology Res       Date:  2010-05-20

9.  Low expression of RecQ-like helicase 5 is associated with poor prognosis in patients with gastric cancer.

Authors:  Yijia Lin; Huashe Wang; Xinyou Wang; Miao Li; Honglei Chen; Junsheng Peng
Journal:  Oncol Lett       Date:  2019-11-21       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.